IL-32, a proinflammatory cytokine in rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1073/PNAS.0511233103PMID 16492735PMCID PMC1413916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism

  2006cited by this paper
• Blocking IL-1 in systemic inflammation

  2005cited by this paper
• IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.

  2005cited by this paper
• Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.

  2005cited by this paper
• Rheumatoid arthritis

  2005cited by this paper
• The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.

  2005cited by this paper
• Interleukin-32A Cytokine and Inducer of TNFα

  2005cited by this paper
• In vivo gene silencing (with siRNA) of pulmonary expression of MIP‐2 versus KC results in divergent effects on hemorrhage‐induced, neutrophil‐mediated septic acute lung injury

  2005cited by this paper
• Interleukin-32: a cytokine and inducer of TNFalpha.

  2005cited by this paper
• Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.

  2004cited by this paper
• Differences in signaling pathways by IL-1beta and IL-18.

  2004cited by this paper
• Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium.

  2004cited by this paper
• Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.

  2004cited by this paper
• Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis

  2004cited by this paper
• Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.

  2004cited by this paper
• Historical review: Cytokines as therapeutics and targets of therapeutics.

  2004cited by this paper
• Toll-Like Receptor 2 Pathway Drives Streptococcal Cell Wall-Induced Joint Inflammation: Critical Role of Myeloid Differentiation Factor 88

  2003cited by this paper
• Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

  2003cited by this paper
• G-Protein-coupled receptors: Lipidated peptides: a therapeutic tool kit

  2002cited by this paper
• Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis.

  2002cited by this paper
• Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

  2002cited by this paper
• Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

  2001cited by this paper
• Dendritic Cells (DCs) in Rheumatoid Arthritis (RA): Progenitor Cells and Soluble Factors Contained in RA Synovial Fluid Yield a Subset of Myeloid DCs That Preferentially Activate Th1 Inflammatory-Type Responses1

  2001cited by this paper
• TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide.

  2001cited by this paper
• Effects of treatment with a fully human anti-tumour necrosis factor α monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFα in patients with rheumatoid arthritis

  2001cited by this paper
• The structure and origin of rheumatoid factors.

  2000cited by this paper
• Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice

  2000cited by this paper
• Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene

  2000cited by this paper
• A proinflammatory role for IL-18 in rheumatoid arthritis.

  1999cited by this paper
• Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

  1999cited by this paper
• Dendritic cells and the pathogenesis of rheumatoid arthritis

  1999cited by this paper
• Synovial tissue analysis in rheumatoid arthritis.

  1999cited by this paper
• Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.

  1998cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

  1995cited by this paper
• Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis

  1995cited by this paper
• Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis.

  1995cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Thl/Th2 CYTOKINE BALANCE IN ARTHRITIS

  year unknowncited by this paper

• Role of IL-32 in RA pathology and potential as a drug target

  2026cites this paper
• Multifaceted role of interleukin-32 in inflammatory diseases and cancer.

  2026cites this paper
• New Cardiovascular Risk Biomarkers in Rheumatoid Arthritis: Implications and Clinical Utility—A Narrative Review

  2025cites this paper
• IL-32γ plays a neuroprotective role after acute stroke in MCAO mouse model

  2025cites this paper
• Exploring the Involvement of New Members of the Interleukin Family in Cardiovascular Disease

  2025influential citation
• The Role of α-Enolase on the Production of Interleukin (IL)-32 in Con A-Mediated Inflammation and Rheumatoid Arthritis (RA)

  2024cites this paper
• Stimulated Human Umbilical Cord Mesenchymal Stem Cells Enhance the Osteogenesis and Cranial Bone Regeneration through IL-32 Mediated P38 Signaling Pathway

  2024cites this paper
• A novel cell source for therapy of knee osteoarthritis using atelocollagen microsphere-adhered adipose-derived stem cells: Impact of synovial fluid exposure on cell activity.

  2024cites this paper
• Estimation of Interleukin 32 and Interleukin 37 Serum Levels in Iraqi Patients with Rheumatoid Arthritis.

  2023cites this paper
• Sputum Interleukin-32 in childhood asthma: correlation with IL-1β

  2023cites this paper
• scGEM: Unveiling the Nested Tree-Structured Gene Co-Expressing Modules in Single Cell Transcriptome Data

  2023cites this paper
• Interleukin-32 as a biomarker in rheumatic diseases: A narrative review

  2023influential citation
• IL-15 promotes inflammatory Th17 cells in the intestine

  2023cites this paper
• Role of mitochondrial dysfunction in the pathogenesis of rheumatoid arthritis: Looking closely at fibroblast- like synoviocytes.

  2023cites this paper
• Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs

  2023cites this paper
• Genetic Association between Polymorphisms of Interleukin-32 and Dilated Cardiomyopathy in Chinese Han Population

  2022cites this paper
• The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases

  2022cites this paper
• Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8.

  2022cites this paper
• Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease

  2022cites this paper
• Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity

  2022cites this paper
• Interleukin-32γ in the Control of Acute Experimental Chagas Disease

  2022cites this paper
• Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway

  2022cites this paper
• A Critical Overview of Interleukin 32 in Leishmaniases

  2022cites this paper
• Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications

  2021cites this paper
• Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19

  2021cites this paper
• Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A

  2021cites this paper
• Alteration in Serum Levels of Calcium in the Patients of Knee Osteoarthritis

  2021cites this paper
• Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ.

  2021cites this paper
• Impact of interleukin-32 germ-line rs28372698 and intronic rs12934561 polymorphisms on cancer development: A systematic review and meta-analysis.

  2021cites this paper
• Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?

  2021cites this paper
• IL-32 Serum Levels in Coronary Artery Disease Patient and its Relationship with IL-6 and TNF-α Serum Levels

  2021cites this paper
• Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-α

  2021cites this paper
• Anti-inflammatory natural products as potential therapeutic agents of rheumatoid arthritis: A systematic review.

  2021cites this paper
• Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population

  2020cites this paper
• Molecular interactions and functions of IL‐32

  2020cites this paper
• Knockdown of IL-32 protects PC12 cells against oxygen-glucose deprivation/reoxygenation-induced injury via activation of Nrf2/NF-κB pathway

  2020cites this paper
• The role of Interleukin‐32 in autoimmunity

  2020cites this paper
• Interleukin 32: A novel player in perioperative neurocognitive disorders.

  2020cites this paper
• IL-31, IL-32 and IL-33 may Serve as Diagnosis Biomarkers in Gastric Cancer

  2020cites this paper
• Influence of Systemic Inflammatory Response to Appearance of New Foci of Chronic Inflammation

  2020cites this paper
• Role of Interleukins on Physiological and Pathological Bone Resorption and Bone Formation: Effects by Cytokines in The IL-12 and IL-17 Families, and by IL-3, IL-32 and IL-34

  2020cites this paper
• Natural Killer Cell Transcript 4 promotes the development of Sjӧgren's syndrome via activation of Rap1 on B cells.

  2020cites this paper
• IL-32 expression associated with lymph vessel invasion in intestinal type of gastric cancer

  2020cites this paper
• Association between interleukin-32 polymorphisms and ovarian cancer in the Chinese Han population.

  2020cites this paper
• Interleukin-32 in Infection, Inflammation and Cancer Biology

  2020cites this paper
• Increased interleukin-32, interleukin-1, and interferon-γ levels in serum from hepatitis B patients and in HBV-stimulated peripheral blood mononuclear cells from healthy volunteers.

  2019cites this paper
• The proinflammatory cytokine TNFα induces DNA demethylation–dependent and –independent activation of interleukin-32 expression

  2019cites this paper
• Treatment with maresin 1, a docosahexaenoic acid-derived pro-resolution lipid, protects skin from inflammation and oxidative stress caused by UVB irradiation

  2019cites this paper
• Early Detection of Peripheral Blood Cell Signature in Children Developing β-Cell Autoimmunity at a Young Age

  2019cites this paper
• Adipose Tissue

  2019cites this paper
• The role of interleukin-32 in infections caused by New World Leishmania species and identification of novel treatment strategies

  2019cites this paper
• Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.

  2019cites this paper
• Interferon-Beta Treatment Differentially Alters TLR2 and TLR4-Dependent Cytokine Production in Multiple Sclerosis Patients

  2019cites this paper
• Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease

  2019cites this paper
• Cytokines and Cytokine Receptors

  2019cites this paper
• Exploring the Role of IL-32 in HIV-Related Kaposi Sarcoma.

  2018cites this paper
• Interleukin-32: its role in asthma and potential as a therapeutic agent

  2018cites this paper
• Elevated Gene Expression of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Peripheral Blood of Chronic Psoriatic Patients

  2018cites this paper
• Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis

  2018influential citation
• Interleukin-32: An endogenous danger signal or master regulator of intracellular pathogen infections-Focus on leishmaniases.

  2018cites this paper
• Immune activation in alpha-1 antitrypsin deficiency related and usual chronic obstructive pulmonary disease

  2018cites this paper
• Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis.

  2018cites this paper
• Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells

  2018cites this paper
• Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients

  2018cites this paper
• IL-32γ attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblasts

  2018cites this paper
• Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes.

  2018cites this paper
• The Lipid Mediator Resolvin D1 Reduces the Skin Inflammation and Oxidative Stress Induced by UV Irradiation in Hairless Mice

  2018cites this paper
• Role of interleukin ‐ 32 in cancer biology ( Review )

  2018cites this paper
• The Biology and Role of Interleukin-32 in Tuberculosis

  2018cites this paper
• Adipokine dysregulation and adipose tissue inflammation in human obesity

  2018cites this paper
• The role of interleukin-32 in the increased cardiovascular risk associated with chronic inflammatory diseases

  2018cites this paper
• Immune markers and proteasomal gene polymorphisms specific for asthma phenotypes

  2018cites this paper
• Role of interleukin-32 in cancer biology.

  2018cites this paper
• Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice

  2018cites this paper
• Chapter 3 Cytokines in Rheumatoid Arthritis ( RA )

  2018cites this paper
• Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis

  2018influential citation
• Interleukin‐32 is highly expressed in lesions of hidradenitis suppurativa

  2017cites this paper
• A review on interleukins: The key manipulators in rheumatoid arthritis

  2017cites this paper
• A case of toxic epidermal necrolysis and vanishing bile duct syndrome, requiring liver transplantation

  2017cites this paper
• Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.

  2017cites this paper
• Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis

  2017cites this paper
• Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets

  2017cites this paper
• Chapter 69 – Etiology and Pathogenesis of Rheumatoid Arthritis

  2017cites this paper
• De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes

  2017cites this paper
• Enhanced dopaminergic neurotoxicity mediated by MPTP in IL‐32&bgr; transgenic mice

  2017cites this paper
• IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression

  2017cites this paper
• Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations

  2017cites this paper
• IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis

  2017cites this paper
• IL-32α-induced inflammation constitutes a link between obesity and colon cancer

  2017cites this paper
• Interleukin 32: a novel player in the control of infectious diseases

  2017cites this paper
• Increased serum interleukin‐32 levels in patients with Behçet's disease

  2017cites this paper
• Decrease in serum IL‐32 level in patients with atopic dermatitis after cyclosporine treatment

  2017cites this paper
• IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis

  2017cites this paper
• Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases.

  2017cites this paper
• Interleukin 32, inflammation and cancer

  2017cites this paper
• Interleukin-32 Gamma as a New Face in Inflammatory Bone Diseases

  2017influential citation
• The Cytokine Network in Pathogenesis of Atopic Dermatitis

  2017cites this paper
• Cytokines in Rheumatoid Arthritis (RA)

  2017cites this paper
• The role of interleukin‐6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis

  2017cites this paper
• Pimaradienoic Acid Inhibits Carrageenan-Induced Inflammatory Leukocyte Recruitment and Edema in Mice: Inhibition of Oxidative Stress, Nitric Oxide and Cytokine Production

  2016cites this paper